Exploring the Latest Advances in Rosacea Treatment: Topical and Oral Options

This article reviews the latest topical and oral treatments for managing rosacea, comparing efficacy and patient outcomes.

Rosacea is a common chronic inflammatory skin condition that primarily affects the face, often causing redness, flushing, and in some cases, papules and pustules. As the understanding of rosacea's pathophysiology improves, so too do the options for effective management. In this article, we will explore the latest topical and oral treatment options, comparing their efficacy and safety profiles. Topical Treatments for Rosacea Topical therapies are usually the first line of treatment for rosacea and are often preferred due to their localized effect and lower systemic exposure. Recent advancements have introduced new formulations that offer enhanced delivery and efficacy. Brimonidine and Oxymetazoline Brimonidine: A selective alpha-2 adrenergic agonist that helps reduce erythema by vasoconstriction. Clinical studies have shown that brimonidine gel can significantly decrease facial redness within 30 minutes of application and maintain its effect for up to 12 hours. Oxymetazoline: Another topical treatment that works similarly to brimonidine, oxymetazoline cream has demonstrated rapid onset and significant improvement in redness, with effects lasting up to 8 hours. Topical Ivermectin Topical ivermectin is another treatment option that possesses both anti-inflammatory and antiparasitic properties. It targets the inflammatory cascade and reduces the presence of Demodex mites, which have been implicated in rosacea. Studies have shown that ivermectin cream can improve both inflammatory lesions and erythema, making it a versatile option. Oral Treatments for Rosacea For patients with moderate to severe rosacea or those who do not respond to topical therapies, oral treatments may be warranted. The most commonly used oral medications include antibiotics and new systemic options. Oral Antibiotics Tetracyclines, such as doxycycline and minocycline, are frequently prescribed for their anti-inflammatory properties rather than their antibacterial effects. Doxycycline, especially in it